In ovarian cancer, NGR-modified biomimetic nanovesicles (NGR-BNVs) achieved efficient delivery of ALKBH5 siRNA, markedly suppressing tumor proliferation and inducing apoptosis. This evidence concerns the gene ALKBH5 and neoplasm.